Publications by authors named "Carlos Forray"

Claim this Profile
E
Efficacy and safety of Lu AF35700 in treatment-resistant schizophrenia: A randomized, active-controlled trial with open-label extension.
John M Kane, Bruce J Kinon, Carlos Forray, Pedro Such, Aurélia Mittoux

Schizophr Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effectiveness of aripiprazole once-monthly for schizophrenia is maintained in the QUALIFY extension study.
Dieter Naber, Ross A Baker, Anna Eramo, Carlos Forray, Karina Hansen

Schizophr Res· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges and opportunities for the development of new antipsychotic drugs.
Carlos Forray, Raimund Buller

Biochem Pharmacol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study.
Steven G Potkin, Jean-Yves Loze, Carlos Forray, Ross A Baker, Christophe Sapin

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFY.
Steven G Potkin, Jean-Yves Loze, Carlos Forray, Ross A Baker, Christophe Sapin

Int Clin Psychopharmacol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidimensional Assessment of Functional Outcomes in Schizophrenia: Results From QUALIFY, a Head-to-Head Trial of Aripiprazole Once-Monthly and Paliperidone Palmitate.
Steven G Potkin, Jean-Yves Loze, Carlos Forray, Ross A Baker, Christophe Sapin

Int J Neuropsychopharmacol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia.
Dieter Naber, Karina Hansen, Carlos Forray, Ross A Baker, Christophe Sapin

Schizophr Res· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Failure to replicate influence of GRIK4 and GNB3 polymorphisms on treatment outcome in major depression.
Alessandro Serretti, Alberto Chiesa, Concetta Crisafulli, Isabelle Massat, Sylvie Linotte, Carlos Forray

Neuropsychobiology· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depression.
Julien Mendlewicz, Concetta Crisafulli, Raffaella Calati, Neslihan Aygun Kocabas, Isabelle Massat, Carlos Forray

Neurosci Lett· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COMT and age at onset in mood disorders: a replication and extension study.
Isabelle Massat, Neslihan Aygun Kocabas, Concetta Crisafulli, Alberto Chiesa, Raffaella Calati, Carlos Forray

Neurosci Lett· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression.
Alessandro Serretti, Alberto Chiesa, Raffaella Calati, Isabelle Massat, Sylvie Linotte, Carlos Forray

Psychiatry Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression.
Alessandro Serretti, Alberto Chiesa, Raffaella Calati, Isabelle Massat, Sylvie Linotte, Carlos Forray

J Affect Disord· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder.
Neslihan Aygun Kocabas, Irina Antonijevic, Carole Faghel, Carlos Forray, Siegfried Kasper

Int Clin Psychopharmacol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: lack of association with clinical phenotypes.
Neslihan Aygun Kocabas, Irina Antonijevic, Carole Faghel, Carlos Forray, Siegfried Kasper

World J Biol Psychiatry· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder.
Magali Noro, Irina Antonijevic, Carlos Forray, Siegfried Kasper, Neslihan Aygun Kocabas

Int Clin Psychopharmacol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and SAR investigations for novel melanin-concentrating hormone 1 receptor (MCH1) antagonists Part 1. The discovery of arylacetamides as viable replacements for the dihydropyrimidinone moiety of an HTS hit.
Yu Jiang, Chien-An Chen, Kai Lu, Irena Daniewska, John De Leon, Carlos Forray

J Med Chem· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and SAR investigations for novel melanin-concentrating hormone 1 receptor (MCH1) antagonists part 2: A hybrid strategy combining key fragments of HTS hits.
Chien-An Chen, Yu Jiang, Kai Lu, Irena Daniewska, Christine G Mazza, Carlos Forray

J Med Chem· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of an alpha1a-adrenergic receptor subtype-selective antagonist from BE2254.
George Chiu, Charles Gluchowski, Carlos Forray

Chem Biol Drug Des· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The MCH receptor family: feeding brain disorders?
Carlos Forray

Curr Opin Pharmacol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist.
Beth Borowsky, Margaret M Durkin, Kristine Ogozalek, Mohammad R Marzabadi, John DeLeon, Carlos Forray

Nat Med· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis